Spiperone derivatives and methods of treating disorders
US8664237B2 · kind B2 · utility
0Cited by
0References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 1, 2009 |
| Grant date | Mar 4, 2014 |
| Priority date | — |
| Expiry date | Apr 23, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are spiperone derivative compounds which have been found to be useful in methods of stimulating CaCC and treating disorders (or symptoms thereof) associated with CaCC including cystic fibrosis, wherein a compound of the invention is administered to a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.